$Neovasc I_老虎社区_美港股上老虎

哼哼哈嘿哟
2018-06-20

$Neovasc Inc(NVCN)$reducer在美国首例患者，好样的！

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

哼哼哈嘿哟
·2018-06-20
嗯嗯，现在迈开第一步。
回复
点赞
举报
收起
- Near:
  早得很，我们应该需要其它的好消息
  2018-06-20
  回复
  举报
Near
·2018-06-20
关键是要改善症状或者通过FDA认可才行
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":206306,"tweetId":"206306","gmtCreate":1529497892990,"gmtModify":1704895205327,"author":{"id":3479604824483521,"idStr":"3479604824483521","authorId":3479604824483521,"authorIdStr":"3479604824483521","name":"哼哼哈嘿哟","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Neovasc Inc(NVCN)$reducer在美国首例患者，好样的！</p></body></html>","htmlText":"<html><head></head><body><p>$Neovasc Inc(NVCN)$reducer在美国首例患者，好样的！</p></body></html>","text":"$Neovasc Inc(NVCN)$reducer在美国首例患者，好样的！","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/206306","repostId":0,"isVote":1,"tweetType":1,"viewCount":3035,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVCN"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":47,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":807994,"commentId":"807994","gmtCreate":1529503893076,"gmtModify":1529503893076,"authorId":3479604824483521,"author":{"id":3479604824483521,"idStr":"3479604824483521","authorId":3479604824483521,"name":"哼哼哈嘿哟","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":206306,"objectIdStr":"206306","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"嗯嗯，现在迈开第一步。","text":"嗯嗯，现在迈开第一步。","html":"嗯嗯，现在迈开第一步。","likeSize":0,"commentSize":1,"subComments":[{"id":808414,"commentId":"808414","gmtCreate":1529508566091,"gmtModify":1529508566091,"authorId":149359872130590,"author":{"id":149359872130590,"idStr":"149359872130590","authorId":149359872130590,"name":"Near","avatar":"https://static.laohu8.com/d7ce24299ed134751b4ad9aa86f99f87","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":206306,"objectIdStr":"206306","type":1,"supId":807994,"supIdStr":"807994","prevId":0,"prevIdStr":"0","content":"早得很，我们应该需要其它的好消息","text":"早得很，我们应该需要其它的好消息","html":"早得很，我们应该需要其它的好消息","disclaimerType":0}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":807837,"commentId":"807837","gmtCreate":1529502056382,"gmtModify":1529502056382,"authorId":149359872130590,"author":{"id":149359872130590,"idStr":"149359872130590","authorId":149359872130590,"name":"Near","avatar":"https://static.laohu8.com/d7ce24299ed134751b4ad9aa86f99f87","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":206306,"objectIdStr":"206306","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"关键是要改善症状或者通过FDA认可才行","text":"关键是要改善症状或者通过FDA认可才行","html":"关键是要改善症状或者通过FDA认可才行","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}

评论（3）

热议股票